Delivery Order SPE2DB22D3016-SPE2DB25FADR0
Award Date
11/18/24
Potential Completion Date
11/19/24
Potential Value
$28K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $13,021.65 and runs through March 7, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition....
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical supplier and distributor, for the provision of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML medication. The contract has a ceiling value of $103,481.69 and a period of performance ending on March 22, 2024. This award is a task order issued under Amerisourcebergen's primary DLA contract, an indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,054.32 delivery order is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a prescription medication. The contract has an ultimate completion date of April 24, 2023 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $12,150.01, is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $20,046.74 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The delivery order is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, with a completion date of January 31, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $8,202.62 award is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $120,958.09 delivery order is for the provision of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML pharmaceutical products. The contract has an ultimate completion date of October 8, 2024 and is a firm fixed-price contract. Amerisourcebergen is a major supplier of pharmaceutical and medical products to various U.S. government agencies, including the DLA Troop...
This federal contract award is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,206.68 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 30, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical worth $13,567.44 to supply 4563034112 REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania with completion by December 8, 2023. This order was awarded against an indefinite delivery contract held by Amerisourcebergen Drug Corp with no set-aside designation used. As a prime contractor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $8,202.62 and is a firm fixed price delivery order that runs through August 2024. No set-aside designation was used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...